Glycomine’s Series C raise highlights investor confidence in the company amid pressure on the paediatric rare disease sector.

Glycomine has bagged a $115 million series C round to continue the progress of its lead candidate through phase 2 development for a rare genetic disorder.

Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial ...

The global continuous renal replacement therapy market revenue was around US$ 1.5 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

The global transparent plastic market size is estimated to reach USD 177.43 billion by 2026 growing at a CAGR of 6.8% during the forecast period, according to a new study published by Report Ocean ...

And GDB International Inc., a N.J.-based plastic film recycler, has restarted the failed Myplas recycling plant in Minnesota.

To shake off the workday stress, employees can take advantage of team outings to sporting events, amusement parks, curling, axe throwing, dinner cruises and on-site charity work. Internal events ...

Designer and conscious traveller Ruchika Sachdeva shares her Japan checklist ...

Asahi Kasei Life Science expects to offer the bioindustry more agile and focused services and deeper innovation in bioprocess ...

Under a five-year framework service agreement signed between Thyssenkrupp Uhde and Brunei Fertilizer Industries, Thyssenkrupp ...

Breaking into Asia’s diverse and dynamic markets has never been more critical — or more competitive. For companies eyeing ...

Amidst global trade tensions and heightened economic uncertainty, Asian markets have not been immune to the volatility, with small-cap stocks facing significant challenges as reflected by the sharp ...